Corona Accelerated R&D in Europe (CARE) is supported by Europe’s Innovative Medicines Initiative (IMI)
Corona Accelerated R&D in Europe (CARE) is supported by Europe’s Innovative Medicines Initiative (IMI). It is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.
The initiative is committed to a long-term understanding of the disease and development of therapies for COVID-19 and future coronavirus threats in addition to urgent efforts to repurpose existing therapies as potential immediate response. The CARE consortium will accelerate COVID-19 R&D by bringing together the leading expertise and projects of 37 teams from academic and non-profit research institutions and pharmaceutical companies into a comprehensive drug discovery engine.
For more information, visit website